Romiplostim prevents chemotherapy-induced thrombocytopenia or low platelet count, reducing bleeding risks in cancer patients ...

An engineer sought a neurologist's opinion after an AI suggested a rare disorder. Despite normal tests, the patient insisted on a specific treatment based on the AI's diagnosis. This case shows how AI ...

Deaths from both causes are down, but they still eclipse all other causes, according to new statistics. By Nina Agrawal Despite gains in treatment, cardiovascular disease remains the leading cause of ...

Please provide your email address to receive an email when new articles are posted on . Adding ianalumab to second-line eltrombopag prolonged time to treatment failure by more than 40%. Researchers ...

Primary immune thrombocytopenia (ITP) is an autoimmune condition where the body’s immune cells mistakenly attack platelets, the blood cells responsible for clotting, which can lead to life-threatening ...

Idiopathic thrombocytopenic purpura (throm-bo-sy-tuh-PEE-nik PURR-puh-ruh), or ITP, is a bleeding disorder in which the blood has an abnormally low amount of a type of blood cell called platelets.

The European Medicines Agency (EMA) has recommended granting marketing authorization for rilzabrutinib (Wayrilz, Sanofi) to treat immune thrombocytopenia (ITP) in adults who are refractory to other ...

How Does Doptelet Work in Thrombocytopenia? Thrombocytopenia is when your blood has too few platelets (also called thrombocytes). Platelets are blood cells made in the soft, spongy tissue inside your ...

Credit: Getty Images More than 20% of ischemic strokes in patients aged 45 years or younger are associated with Antiphospholipid syndrome, but its exact etiology and pathophysiology are not yet fully ...

The addition of ianalumab to eltrombopag significantly prolonged the duration of safe platelet levels. Ianalumab added to eltrombopag significantly prolonged the time to treatment failure (TTF) in ...